ArticleJournal of managed care & specialty pharmacy2025

Addition of continuous glucose monitoring to glucagon-like peptide 1 receptor agonist treatment for type 2 diabetes mellitus - An economic evaluation.

Eugene E Wright et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.